Does Time-in-Range Matter? Perspectives From People With Diabetes on the Success of Current Therapies and the Drivers of Improved Outcomes

IN BRIEF After assessing patient perspectives on the success of current diabetes therapies and the factors that have the greatest impact on daily life, we show that time-in-range is a crucial outcome for people with diabetes and that current therapies are falling short on this metric. We also show t...

Descripción completa

Detalles Bibliográficos
Autores principales: Runge, Ava S., Kennedy, Lynn, Brown, Adam S., Dove, Abigail E., Levine, Brian J., Koontz, Sophie P., Iyengar, Varun S., Odeh, Sarah A., Close, Kelly L., Hirsch, Irl B., Wood, Richard
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Diabetes Association 2018
Materias:
Feature Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5898169/
https://www.ncbi.nlm.nih.gov/pubmed/29686449
http://dx.doi.org/10.2337/cd17-0094
Descripción
Sumario:IN BRIEF After assessing patient perspectives on the success of current diabetes therapies and the factors that have the greatest impact on daily life, we show that time-in-range is a crucial outcome for people with diabetes and that current therapies are falling short on this metric. We also show that patients feel significant stress and worry, and they believe they are falling short in diet, exercise, and weight maintenance. In addition, they believe diet and exercise and in-range blood glucose are the biggest drivers of improved diabetes management and mindset. Together, these findings support the need for therapies that improve outcomes including and beyond A1C.

Ejemplares similares